EQS-News: ElringKlinger AG
/ Key word(s): Personnel
ElringKlinger AG: Dr. Stefan Wolf set to leave ElringKlinger at the end of June 2023 Dettingen/Erms (Germany), April 6, 2023 +++ The Supervisory Board and the Chairman of the Management Board (CEO) of ElringKlinger AG, Dr. Stefan Wolf, have agreed by mutual consent to terminate Dr. Wolf's contract as of June 30, 2023. Dr. Wolf was with ElringKlinger AG for a total of 26 years, during which time he held the position of CEO for 17 years. Klaus Eberhardt, Chairman of the Supervisory Board of ElringKlinger AG: "On behalf of the Supervisory Board, I would like to thank Dr. Stefan Wolf for his successful and long-standing track record at ElringKlinger AG. Of particular merit are his achievements in establishing and evolving the areas of fuel cell and battery technology, which he identified and promoted at an early stage and with great foresight as foundations for ElringKlinger AG in pursuit of the transformation currently taking place in the automobile and automotive supply industry. These are to be seen as key milestones for the company." Dr. Wolf's duties will be performed on an interim basis by Mr. Thomas Jessulat, Chief Financial Officer, as from July 1, 2023. Mr. Jessulat will also temporarily assume the role of Spokesperson of the Management Board. At the same time, the Supervisory Board has begun the process of appointing a successor.
For further information, please contact:
About ElringKlinger AG
06.04.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
Language: | English |
Company: | ElringKlinger AG |
Max-Eyth-Straße 2 | |
72581 Dettingen/Erms | |
Germany | |
Phone: | 071 23 / 724-0 |
Fax: | 071 23 / 724-9006 |
E-mail: | jens.winter@elringklinger.com |
Internet: | www.elringklinger.de |
ISIN: | DE0007856023 |
WKN: | 785602 |
Listed: | Regulated Market in Frankfurt (Prime Standard), Stuttgart; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Tradegate Exchange |
EQS News ID: | 1603379 |
End of News | EQS News Service |
|
1603379 06.04.2023 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.